The ability to distinguish between intra-abdominal and subcutaneous abdominal fat may be important in epidemiologic and clinical research. In this study anthropometric measurements were taken from 71 men and 34 women presenting for routine computed tomography (CT). Areas of abdominal fat were calculated from CT scans made at the level of the L4 vertebra. The amounts of intra-abdominal and subcutaneous abdominal fat could be accurately predicted from several circumferences, skinfold measurements, body mass index, and age (R2 ranged from 0.79 to 0.84). In addition, it was found that the area of intra-abdominal fat on the CT scan was related to the waist:hip circumference ratio (r = 0.75 in men, r = 0.55 in women) and to the waist:thigh circumference ratio (r = 0.55 in men, r = 0.70 in women). The correlations of the circumference ratios with the areas of subcutaneous fat were invariably lower.
Our objective in this study was to investigate the usefulness of an anti-scatter grid in digital mammography using a contrast detail phantom. The mammography system we investigated was a GE Senographe 2000D. We carried out phantom measurements under various conditions with and without using the anti-scatter grid. A new version of the CDMAM phantom (version 3.4) was used. This phantom consists of a matrix of square cells with disks of varying size and contrast. For given exposure conditions detectability of these disks can be determined and used for construction of contrast detail curves. Previously, a computer program was developed at our institute that performs a fully automatic analysis of the phantom recordings using the ideal observer model. Breast thickness was simulated by a homogeneous layer of PMMA in the range of 1 to 7 cm. Series of images were recorded for different KeV and target-filter combinations depending on the simulated thickness. The dose was kept constant for each thickness with and without using a grid. It appeared that image quality improved for simulated breast thickness below 5 cm when the grid was removed. In the range from 5 to 7 cm contrast detail curves obtained with or without a grid were similar. Results suggest that for compressed breast thickness in the range of 1 to 7 cm a grid might not be needed in the digital mammography system we investigated. Below 5 cm, omitting the grid may allow lower dose to the patient without losing image quality.
The nationwide breast cancer screening programme using mammography has been in full operation in The Netherlands since 1997. There is concern that the mean glandular doses due to mammography might be differing between different regions of the country due to differences in glandularity and compressed breast thickness. To investigate regional differences, glandularity, compressed breast thickness and mean glandular dose were determined for individual breasts during screening at mammography units at four locations in The Netherlands. Differences in glandularity were observed, which could be related qualitatively to differences in age of the participants at the different locations. Mean glandular dose depends on compressed breast thickness, glandularity and technical conditions of screening. The lowest average value of the mean glandular dose was found for the unit in Amsterdam. This is most likely due to the use of the Mo/Rh anode/filter combination at this unit, in addition to the Mo/Mo combination. At the other three units, almost exclusively the Mo/Mo anode/filter combination was used. Differences in mean glandular dose averaged per unit could be related mainly to differences in tube-current exposure-time product values. Consequently, it is concluded that differences in mean glandular dose at different units are marginal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.